MRNA - Moderna Inc
IEX Last Trade
77.35
-0.240 -0.310%
Share volume: 3,582,437
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$77.59
-0.24
-0.31%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-03 | 2023-02-24 | 2023-05-04 | 2023-08-03 | 2023-11-03 | 2024-02-23 | 2024-05-02 | 2024-08-01 | |
Total revenue | 3.364 B | 5.084 B | 1.862 B | 344.000 M | 1.831 B | 2.811 B | 167.000 M | 241.000 M | |
Cost of revenue | 1.100 B | 1.918 B | 792.000 M | 731.000 M | 2.241 B | 929.000 M | 96.000 M | 115.000 M | |
Gross profit | 2.264 B | 3.166 B | 1.070 B | -387.000 M | -410.000 M | 1.882 B | 71.000 M | 126.000 M | |
39.84% | -66.20% | -136.17% | -5.94% | 559.02% | -96.23% | 77.46% | |||
Operating expenses | 1.098 B | 1.586 B | 1.436 B | 1.480 B | 1.602 B | 1.876 B | 1.337 B | 1.489 B | |
Selling general and admin | 278.000 M | 375.000 M | 305.000 M | 332.000 M | 442.000 M | 470.000 M | 274.000 M | 268.000 M | |
Research and development | 820.000 M | 1.211 B | 1.131 B | 1.148 B | 1.160 B | 1.406 B | 1.063 B | 1.221 B | |
Total expenses | 2.198 B | 3.504 B | 2.228 B | 2.211 B | 3.843 B | 2.805 B | 1.433 B | 1.604 B | |
59.42% | -36.42% | -0.76% | 73.81% | -27.01% | -48.91% | 11.93% | |||
Operating income | 1.166 B | 1.580 B | -366.000 M | -1.867 B | -2.012 B | 6.000 M | -1.266 B | -1.363 B | |
Ebit | 1.166 B | 1.580 B | -366.000 M | -1.867 B | -2.012 B | 6.000 M | -1.266 B | -1.363 B | |
Pretax income | 1.217 B | 1.655 B | -305.000 M | -1.749 B | -1.958 B | 70.000 M | -1.165 B | -1.279 B | |
35.99% | -118.43% | 473.44% | 11.95% | -103.58% | -1,764.29% | 9.79% | |||
Income tax | 174.000 M | 190.000 M | -384.000 M | -369.000 M | 1.672 B | -147.000 M | 10.000 M | 0.000 | |
Net income basic | 1.043 B | 1.465 B | 79.000 M | -1.380 B | -3.630 B | 217.000 M | -1.175 B | -1.279 B | |
40.46% | -94.61% | -1,846.84% | -163.04% | 105.98% | -641.47% | -8.85% | |||
Net income | 1.043 B | 1.465 B | 79.000 M | -1.380 B | -3.630 B | 217.000 M | -1.175 B | -1.279 B | |
40.46% | -94.61% | -1,846.84% | -163.04% | 105.98% | -641.47% | -8.85% |